51 results
Page 2 of 3
6-K
EX-99.1
vy9hrl2
9 Nov 20
ObsEva appoints Brian O’Callaghan as Chief Executive Officer
7:32am
6-K
EX-99.1
k9zs18diweegnc
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
1qiea9l g4jf6bmp5
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-99.2
aqppeg
6 Aug 20
Index to Unaudited Condensed Consolidated Financial Statements
6:53am
6-K
EX-99.1
qfkzrhuhwy8tb6
1 Jul 20
ObsEva and Yuyuan BioScience Technology Announce Submission of the Pre-IND Dossier for Nolasiban with the Chinese NMPA
6:15am
6-K
EX-99.3
agvxsx54lq7veheq
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am
6-K
EX-99.2
q2s7e8wa63zf 0fx
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am
6-K
pejuj9oxw w9h0e
15 Jan 20
Current report (foreign)
8:35pm
6-K
g3miavx8cm95e7lwc8
13 Nov 19
Index to Unaudited Condensed Consolidated Financial Statements
4:00pm
6-K
EX-99.1
yl962nbxvm8y2yhuq74q
7 Aug 19
Current report (foreign)
7:21am
6-K
EX-99.2
l7uuz5r 4r
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.1
gok8vhff34p1t wna
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
e6jcghhzo7
9 Oct 18
Current report (foreign)
4:42pm